MRFF - 2019 Cardiovascular Health

TIMELINE

ASAP

Notice of Intent (NOI) registration OPEN

10am, 20 Jan 2020 (Monday)

Draft Grant Proposal due to RIC for strategic review. Early submission encouraged.

5pm, 29 Jan 2020 (Wednesday)

Draft application due to RIC for compliance and eligibility check (including other supporting documents)

5pm, 29 Jan 2020 (Wednesday)

Minimum Data due on RGMS

10am, 10 Feb 2020 (Monday)

Authority to Submit due to RIC

5pm, 10 Feb 2020 (Monday)

Final application submitted to RIC

5pm, 12 Feb 2020 (Wednesday)

Final application submitted to NHMRC

Overview

The objective of this Cardiovascular Health Grant Opportunity is to support multidisciplinary and collaborative approaches in three priority areas to drive significant improvements in cardiovascular health and stroke outcomes such as disability, mortality and morbidity.

You are required to nominate the priority area your research project aims to address, noting more than one area can be addressed through a single project. If your project addresses more than one priority area, submit your proposal to the area that most closely relates to the primary focus of your research.

Funding will be provided to the top ranked application in each of the three priority areas. The remaining funding will then be provided in rank order to the best ranked applications from across all priority areas.

  • Priority 1: Improving prevention of heart disease and stroke
  • Priority 2: Improved survival outcomes after an acute heart or stroke event through a focus on treatment
  • Priority 3: Improving secondary prevention and survivorship after a cardiovascular event

Research undertaken in this priority area should primarily involve:
- innovative approaches to support effective, long term secondary prevention
- improving outcomes from cardiovascular and/or stroke events through novel and personalised secondary prevention strategies to maximise post-event wellness and minimise recurrent and repeat hospitalisation
- reducing premature disability, mortality and morbidity
- improving access to effective strategies (for example rehabilitation) and/or improvements in current treatments.

Funding

The Australian Government has announced a total of $220 million for the Mission. For this Grant Opportunity, up to $12 million of funding is available in 2019-20. Minimum and maximum amounts of funding that can be requested for each grant are $1 million and $3 million, respectively.

2019-202020-212021-22
$12.0m Nil Nil

The maximum grant period is three years.

Eligibility

- A person must not be named as a Chief Investigator (CI) on more than one application submitted to this grant opportunity.

- You are not eligible if your research proposal was submitted to the MRFF International Clinical Trial Collaboration (ICTC) Program and it is currently being assessed, or is included in the ICTC Merit List. Chief Investigators on an application submitted to the ICTC Program that is currently being assessed or is included in the ICTC Merit List are eligible to submit a different research proposal to this grant opportunity.

- The proposed research should not duplicate research previously or currently being undertaken. The NHMRC may compare the research proposed in grant applications with grants previously or currently funded by the MRFF, NHMRC or other agencies (e.g. Australian Research Council) and published research (see also section 4.7 – Other ineligible expenditure)

How to apply

  1. Notice of Intent: Please register your Notice of Intent if you are considering applying for the MRFF RCRDUN.  RIC-MRFF team will then contact each applicant with further information.
  2. Update RGMS Profile: Each CI must obtain access to RGMS and update profile information (see RGMS information)
  3. Review documentation: Review the  grant guidelines and category descriptors available below and Grant Connect.
  4. Create and Complete the application:  Log in to RGMS select "MRFF - Research Grant" from Initiatives and then select the relevant scheme from Round and complete the application.
  5. Submit “Review Ready” application to RIC: Submit application to RIC within the RIC internal submission period for review.
  6. Complete application: After taking feedback from the RIC team into consideration, complete the application in RGMS. It is suggested advice is sought from colleagues, Faculty Mentors, etc. before finalising the application.
  7. Submit the UoM Authority to Submit Form:
  8. This form must be submitted to RIC electronically by the final internal closing date. This form should include:

    • Complete the compliance and eligibility section
    • Signature of all CIs and AIs

    Electronic signatures and email consent are permitted.

    This is an NHMRC requirement and the application cannot be submitted to NHMRC until received.

  9. Final Submission:
    • On the final internal closing date, the applicant must:
    • Submit finalised application by clicking ‘Submit to RAO’ in RGMS
    • Email RIC enquiries-mrff@unimelb.edu.au as well as a scanned, signed Authority to Submit form.
    • Should you require further information please contact Alvin Wong on 83449352 or via email
  10. RIC will submit the application: Once the application has been submitted to NHMRC, you will receive an email from RIC confirming submission.

Supporting documents

NHMRC Documents

Grant Guidelines

Assessment Criteria

Rating Scale for Overall Value and Risk

Minimum Data

Addendum 1

RIC Documents

Summary and Tips

Grant Proposal Template  (Including Assessment Criteria)

Grant Guidelines - UoM highlighted

Authority to Submit Form

Wording for written consent

Contacts

MRFF Cardiovascular Health questions and primary email
enquiries-mrff@unimelb.edu.au

Key Contacts

Contact
Alvin Wong and Catherine Nobes
Email
enquiries-mrff@unimelb.edu.au
Phone
T: Alvin - +61 3 8344 9352; Catherine - +61 3 8344 1471